AzTrials
AzTrials

Mechanical Ventilation Complicationi-SyncNCT06295237

Automatic Adjustment for Asynchronies During Mechanical Ventilation

A study testing Intellisync+ in people with Mechanical Ventilation Complication, run by Hospital San Carlos, Madrid at 1 site in Spain.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Asynchronies between the patient and the artificial ventilator are a frequent problem. They may cause altered sleep, ventilator-induced lung injury, prolong length of ICU stay, cause neuro-psycologic complications and increase mortality. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Mechanical Ventilation Complication
What is being tested?
Intellisync+
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteSpain
Study dates
15 Feb 2024to 15 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age >17 years
  • Partial ventilatory support ("SPONT" mode) connected to Hamilton C1 model, irrespective of chronic restrictive or obstructive lung disease, categorized by RCexp (Expiratory time constant): restrictive (RCExp <0.6); obstructive (RCExp >0.9); normal (RCExp 0.6 - 0.9).
  • Software version SW3.0.0 or superior and the IntelliSync+ software tool available in invasive and non-invasive ventilation.
  • Presence of asyncronies in pressure and volume curves tracings of the ventilator.
  • Signed informed content.

Who cannot join

  • Pregnant
  • On extracorporeal respiratory support (ECMO or ECCO2R)

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Hospital Clinico San Carlos

    Madrid, Madrid, 28040

Other trials in Spain

About this study

Official title: Comparison of the Prevalence of Asynchronies During Mechanical Ventilation With Manual Versus Automatic Adjustment Ventilator Settings Using the INTELLISYNC+® (HAMILTON) Tool. A Randomized Controlled Study

Asynchronies between the patient and the artificial ventilator are a frequent problem. They may cause altered sleep, ventilator-induced lung injury, prolong length of ICU stay, cause neuro-psycologic complications and increase mortality. Although reducing their incidence through ventilator setting adjustments is possible, they frequently go undetected and it also requires that attendings remain at the bedside to repeatedly modify ventilator parameters. Ventilator systems may detect and automatically adjust parameters of mechanical ventilation. This would avoid delays in detection and adjustment if the intensivist is not immediately available. The investigators intend to study an automatic detection and adjustment tool which is incorporated in the ventilator software.

Read the detailed description

The prevalence and time course of asynchronies will be evaluated in subjects under invasive (n=40) or non-invasive (n=40) mechanical ventilation. Intensivist-optimized ventilator settings will be compared to a software tool (Hamilton ventilators, Intellisync+) in its capacity to control and adjust the triggering and cycling by analysis of the ventilator curves.

The outcome variable is the percentage of the duration of asynchronies during the two 2-hour study periods.

This pilot study has a prospective, randomized cross-over design. The order of the 2 study periods will be randomized to either start with "control" with manual adjustment or "automated adjustment" with Intellisync+.

The total sample size is 80 subjects, 40 receiving invasive mechanical ventilation and 40 on non-invasive mechanical ventilation.

Being tested
Intellisync+
Keywords
Asyncronies, Mechanical ventilation, Automatic detection and adjustment

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intellisync+Device

    mechanical ventilator software automatically detecting and adjusting ventilator parameters to control or reduce the number of events.

Study groups in NCT06295237
Study groupRoleWhat they receive
Standard of CareNo interventionOptimized ventilator settings to control and reduce the number of asynchronies
Activated automatic detection and adjustment of asynchroniesActive comparatorActive mode of a mechanical ventilator software automatically detecting and adjusting ventilator parameters to control or reduce the number of events.
Receives: Device: Intellisync+

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Duration of asyncronies

    duration of asyncronies expressed as percentage of time during the respective 2-hour study periods

    Measured: two hours per study arm

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Mar 2024
  2. Study start15 Feb 2024
  3. Primary completion15 Dec 2024
  4. Study completion15 Dec 2024

Why it stopped: Futility. Intermediate analysis shows no difference in outcome variables

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
Two 2-hour periods: 1) "off mode" consisting of a control period with optimized ventilator parameters and 2) "on mode" with an active automated detection and adjustment for asynchronies. The starting first period is randomized.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06295237
Sponsor's protocol ID
i-Sync
Acronym
i-Sync
Status last verified
Mar 2025
First submitted
28 Feb 2024
Last updated
7 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Intellisync+ in people with Mechanical Ventilation Complication, run by Hospital San Carlos, Madrid at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 7 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Futility. Intermediate analysis shows no difference in outcome variables). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Duration of asyncronies (time frame: two hours per study arm). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Mar 2025; AzTrials last refreshed its copy on 29 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in